WRM
REGN icon

Westport Resources Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Westport Resources Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-200
Closed -$82K – 1026
2014
Q4 		$82K Hold
200
– – 0.02% 453
2014
Q3 		$72K Hold
200
– – 0.02% 481
2014
Q2 		$56K Hold
200
– – 0.02% 529
2014
Q1 		$60K Hold
200
– – 0.02% 532
2013
Q4 		$55K Hold
200
– – 0.02% 548
2013
Q3 		$63K Hold
200
– – 0.02% 479
2013
Q2 		$45K Buy
+200
New +$46.6K 0.02% 528

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westport Resources Management's REGN Position: Q1 2015 in Review

Westport Resources Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2015, closing a stake of 200 shares — an estimated $82K sold.

Westport Resources Management first reported a position in REGN in Q2 2013 and held it in 7 quarters. The position peaked at $82K in Q4 2014. 509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

  • Westport Resources Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Westport Resources Management sold 200 Regeneron Pharmaceuticals shares in Q1 2015, an estimated $82K.
  • Westport Resources Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Westport Resources Management's Regeneron Pharmaceuticals position peaked at $82K in Q4 2014.
  • 509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on Westport Resources Management's 13F filing for Q1 2015, filed 5 May 2015.